Brief: Medicus Pharma Ltd Clarifies Positive Skinject Phase 2 Dataset

Medicus Pharma

01/04/2026 13:02

April 1 (Reuters) - Medicus Pharma Ltd MDCX.O:

MEDICUS PHARMA LTD CLARIFIES POSITIVE SKINJECT PHASE 2 DATASET

MEDICUS PHARMA LTD - DATASET SUPPORTS SKINJECT DEVELOPMENT, REGULATORY DISCUSSIONS, AND STRATEGIC PARTNERSHIPS

MEDICUS PHARMA LTD - DEVELOPMENT FOCUS IS ON ACTIVE TREATMENT ARMS IN PHASE 2 STUDY

MEDICUS PHARMA: PHASE 2 STUDY IS "PROOF OF CONCEPT" EXPLORATORY STUDY, PRIMARILY FOCUSED ON ACHIEVING MEANINGFUL CLINICAL (VISUAL) CLEARANCE

Source text: ID:nGNX1Y3Cmv

Further company coverage: MDCX.O

 ((Reuters.Briefs@thomsonreuters.com;))